384 related articles for article (PubMed ID: 26552025)
1. [Clinical features of patients with juvenile and adult dermatomyositis].
Szalmás O; Nagy-Vince M; Dankó K; Farkas F
Orv Hetil; 2015 Sep; 156(37):1491-6. PubMed ID: 26552025
[TBL] [Abstract][Full Text] [Related]
2. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K
Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656
[TBL] [Abstract][Full Text] [Related]
3. [Disease course, frequency of relapses and survival of patients with juvenile or adult dermatomyositis].
Constantin T; Ponyi A; Kálovics T; Orbán I; Molnár K; Dérfalvy B; Dicso F; Sallai A; Garami M; Balogh Z; Szalai Z; Fekete G; Dankó K
Orv Hetil; 2007 Oct; 148(42):1989-97. PubMed ID: 17932005
[TBL] [Abstract][Full Text] [Related]
4. Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center.
Nitiyarom R; Charuvanij S; Likasitwattanakul S; Thanoophunchai C; Wisuthsarewong W
Indian J Dermatol Venereol Leprol; 2022; 88(2):162-170. PubMed ID: 34491668
[TBL] [Abstract][Full Text] [Related]
5. [Juvenile dermatomyositis: diagnosis and treatment].
Gissinger-Prévot S; Figarella-Branger D; Mancini J; Chabrol B
Arch Pediatr; 2008 Jan; 15(1):50-3. PubMed ID: 18164188
[TBL] [Abstract][Full Text] [Related]
6. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis].
Váncsa A; Dankó K
Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067
[TBL] [Abstract][Full Text] [Related]
7. Juvenile dermatomyositis in Thai children.
Singalavanija S; Liamsuwan S; Limpongsanurak W; Raungsuwan S
J Med Assoc Thai; 2001 Nov; 84(11):1527-33. PubMed ID: 11853294
[TBL] [Abstract][Full Text] [Related]
8. [Polymyositis and dermatomyositis in childhood].
Rodríguez Núñez A; Fernández Bustillo JM; Rodríguez Pérez E; Novo Rodríguez I; Pérez Becerra E; Peña Guitián J; Castro Gago M
An Esp Pediatr; 1988 Oct; 29(4):288-92. PubMed ID: 3069018
[TBL] [Abstract][Full Text] [Related]
9. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.
Rider LG; Katz JD; Jones OY
Rheum Dis Clin North Am; 2013 Nov; 39(4):877-904. PubMed ID: 24182859
[TBL] [Abstract][Full Text] [Related]
10. Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin.
Shahani L
BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22907859
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics of juvenile dermatomyositis].
Constantin T; Ponyi A; Garami M; Gergely L; Fekete G; Dankó K
Orv Hetil; 2003 Jun; 144(25):1245-50. PubMed ID: 12901181
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine-induced haemolytic anaemia in a child with juvenile dermatomyositis.
Queirós G; Romeira AM; Brito MJ; Conde M
BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 22977058
[TBL] [Abstract][Full Text] [Related]
13. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content.
Manlhiot C; Tyrrell PN; Liang L; Atkinson AR; Lau W; Feldman BM
Pediatrics; 2008 Mar; 121(3):e626-30. PubMed ID: 18299304
[TBL] [Abstract][Full Text] [Related]
14. Update on therapy for refractory dermatomyositis and polymyositis.
Villalba L; Adams EM
Curr Opin Rheumatol; 1996 Nov; 8(6):544-51. PubMed ID: 9018458
[TBL] [Abstract][Full Text] [Related]
15. Outcome in juvenile dermatomyositis.
Chowdhary V; Wakhlu A; Agarwal A; Misra R
Indian Pediatr; 2002 Oct; 39(10):931-5. PubMed ID: 12428038
[TBL] [Abstract][Full Text] [Related]
16. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.
Kim S; El-Hallak M; Dedeoglu F; Zurakowski D; Fuhlbrigge RC; Sundel RP
Arthritis Rheum; 2009 Jun; 60(6):1825-1830. PubMed ID: 19479872
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of juvenile dermatomyositis complicated with interstitial lung disease].
Chen L; Hu Y; Yao Y; Zhen XF; Chen F; He Q; Mo X; Ma SC
Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):465-9. PubMed ID: 22931947
[TBL] [Abstract][Full Text] [Related]
18. Juvenile dermatomyositis.
Halbert AR
Australas J Dermatol; 1996 May; 37(2):106-8. PubMed ID: 8687325
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
Ogimi C; Honma N; Tanaka R; Oh-ishi T
Mod Rheumatol; 2012 Apr; 22(2):280-3. PubMed ID: 21710356
[TBL] [Abstract][Full Text] [Related]
20. Twelve years experience of juvenile dermatomyositis in North India.
Singh S; Bansal A
Rheumatol Int; 2006 Apr; 26(6):510-5. PubMed ID: 16163542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
